PURPOSE: The purpose of the study was to evaluate the impact of left atrial posterior wall isolation (LAPWI) in addition to pulmonary vein isolation (PVI) vs PVI alone, performed using CB-A, in patients with PAF on a midterm follow-up of 12 months. METHODS: Eighty consecutive patients indicated to index cryoballoon ablation (CB-A) for the treatment of drug resistant PAF were included. The first 50 (62.5%) underwent PVI only, and the following 30 patients (37.5%) underwent LAPWI + PVI. RESULTS: Acute isolation was achieved in all PVs in both groups. The LAPW was successfully isolated in 29 out of 30 (97%) patients; in the remaining patient, adjunct radiofrequency ablation was required. The total procedure time and the mean fluoroscopy time were significantly shorter in patients who underwent PV isolation only (p < 0.001). The freedom from atrial fibrillation (AF) at 12 months was not significantly different between the 2 groups (LAPW + PVI = 90% vs PVI = 88%) (log-rank p = 0.816). CONCLUSION: LAPW ablation in addition to PVI by the means of CB-A does not seem to reduce the risk of AF recurrence if compared with the standard PVI on a midterm follow-up of 12 months.
PURPOSE: The purpose of the study was to evaluate the impact of left atrial posterior wall isolation (LAPWI) in addition to pulmonary vein isolation (PVI) vs PVI alone, performed using CB-A, in patients with PAF on a midterm follow-up of 12 months. METHODS: Eighty consecutive patients indicated to index cryoballoon ablation (CB-A) for the treatment of drug resistant PAF were included. The first 50 (62.5%) underwent PVI only, and the following 30 patients (37.5%) underwent LAPWI + PVI. RESULTS: Acute isolation was achieved in all PVs in both groups. The LAPW was successfully isolated in 29 out of 30 (97%) patients; in the remaining patient, adjunct radiofrequency ablation was required. The total procedure time and the mean fluoroscopy time were significantly shorter in patients who underwent PV isolation only (p < 0.001). The freedom from atrial fibrillation (AF) at 12 months was not significantly different between the 2 groups (LAPW + PVI = 90% vs PVI = 88%) (log-rank p = 0.816). CONCLUSION: LAPW ablation in addition to PVI by the means of CB-A does not seem to reduce the risk of AF recurrence if compared with the standard PVI on a midterm follow-up of 12 months.
Authors: Alexander Fürnkranz; K R Julian Chun; Andreas Metzner; Dieter Nuyens; Boris Schmidt; Andre Burchard; Roland Tilz; Feifan Ouyang; Karl Heinz Kuck Journal: J Cardiovasc Electrophysiol Date: 2010-03-05
Authors: Malte Kuniss; Harald Greiß; Dmitri Pajitnev; Ersan Akkaya; Nikolas Deubner; Andreas Hain; Lars Bodammer; Alexander Berkowitsch; Gian-Battista Chierchia; Christian W Hamm; Thomas Neumann Journal: Europace Date: 2017-07-01 Impact factor: 5.214
Authors: Luigi Pannone; Antonio Bisignani; Antonio Sorgente; Anaïs Gauthey; Domenico G Della Rocca; Cinzia Monaco; Wim Bories; Robbert Ramak; Ingrid Overeinder; Gezim Bala; Alexandre Almorad; Saverio Iacopino; Gaetano Paparella; Erwin Ströker; Juan Sieira; Panagiotis Flamée; Pedro Brugada; Mark La Meir; Gian-Battista Chierchia; Carlo De Asmundis Journal: J Clin Med Date: 2022-05-23 Impact factor: 4.964
Authors: Antonio Bisignani; Luigi Pannone; Gezim Bala; Shuichiro Kazawa; Paul Calburean; Ingrid Overeinder; Cinzia Monaco; Felicia Lipartiti; Vincenzo Miraglia; Sergio Rizzi; Maysam Al Housari; Joerelle Mojica; Antanas Strazdas; Thiago Guimarães Osório; Juan Sieira; Saverio Iacopino; Alexandre Almorad; Erwin Ströker; Antonio Sorgente; Pedro Brugada; Carlo de Asmundis; Gian-Battista Chierchia Journal: J Arrhythm Date: 2021-08-10